Vivos Therapeutics Share Price Today
(NASDAQ: VVOS)

Name: Vivos Therapeutics Share Price Today (NASDAQ: VVOS) - Vivos Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Vivos Therapeutics share price is $3.6 & ₹309.54 as on 22 Mar 2025, 2.30 'hrs' IST

$3.6

▲

0.09

(2.56%)

Market is closed - opens 7 PM, 24 Mar 2025

View live Vivos Therapeutics share price in Dollar and Rupees. Guide to invest in Vivos Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vivos Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Vivos Therapeutics share price movements

Today's Low: $3.45
Today's High: $3.68
$3.60
4.17%
Downside
Day's Volatility :6.27%
Upside
2.2%
52 Weeks Low: $1.91
52 Weeks High: $6.28
$3.60
46.94%
Downside
52 Weeks Volatility :69.59%
Upside
42.68%

Vivos Therapeutics (VVOS) Returns

Period	Vivos Therapeutics Inc	Index (Russel 2000)
3 Months	-29.69%	0.0%
6 Months	22.87%	0.0%
1 Year	-20.88%	0.0%
3 Years	-94.33%	-13.8%

Vivos Therapeutics (VVOS) Key Statistics

in dollars & INR

Previous Close	$3.51
Open	$3.52
Today's High	$3.6808
Today's Low	$3.45
Market Capitalization	$21.2M
Today's Volume	$62.0K
52 Week High	$6.28
52 Week Low	$1.91
Revenue TTM	$14.6M
EBITDA	$-11.9M
Earnings Per Share (EPS)	$-5.13
Profit Margin	-86.19%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-325.98%

How to invest in Vivos Therapeutics Stock (VVOS) from India?

It is very easy for Indian residents to invest directly in Vivos Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vivos Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vivos Therapeutics or VVOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vivos Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vivos Therapeutics shares which would translate to 0.239 fractional shares of Vivos Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vivos Therapeutics, in just a few clicks!

Returns in Vivos Therapeutics (VVOS) for Indian investors in Rupees

The Vivos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Vivos Therapeutics investment value today

Current value as on today

₹82,315

Returns

₹17,685

(-17.69%)

Returns from Vivos Therapeutics Stock

₹20,879 (-20.88%)

Dollar Returns

₹3,194 (+3.19%)

Indian investors sentiment towards Vivos Therapeutics (VVOS)

-4%

Period: Feb 21, 2025 to Mar 23, 2025. Change in 30 Days versus previous period

Search interest for Vivos Therapeutics Stock from India on INDmoney has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vivos Therapeutics

Anson Funds Management LP
4.12%
Strategic Wealth Designers
1.70%
Geode Capital Management, LLC
0.76%
Cutter & CO Brokerage, Inc.
0.65%
Commonwealth Equity Services Inc
0.44%
Vanguard Group Inc
0.18%

Analyst Recommendation on Vivos Therapeutics

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Vivos Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Vivos Therapeutics Stock (VVOS)

What analysts predicted

Upside of 75.0%

Target:

$6.30

Current:

$3.60

Insights on Vivos Therapeutics Stock (Ticker Symbol: VVOS)

Price Movement
In the last 7 days, VVOS stock has moved up by 9.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 4.05M → 3.86M (in $), with an average decrease of 4.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.93M → -2.61M (in $), with an average decrease of 35.5% per quarter
VVOS vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 48.9% return, outperforming this stock by 76.0%
VVOS vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.0% return, outperforming this stock by 232.4%
Price to Sales
ForVVOS every $1 of sales, investors are willing to pay $0.9, whereas for Boston Scientific Corp., the investors are paying $8.8 for every $1 of sales.

VVOS Vivos Therapeutics Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$11.4M	↑ 200.43%
Net Income	$-10.9M	↑ 27.51%
Net Profit Margin	-95.6%	↑ 129.65%

	FY20	Y/Y Change
Revenue	$13.1M	↑ 14.68%
Net Income	$-8.8M	↓ 19.0%
Net Profit Margin	-67.52%	↑ 28.08%

	FY21	Y/Y Change
Revenue	$16.9M	↑ 29.23%
Net Income	$-20.3M	↑ 130.0%
Net Profit Margin	-120.18%	↓ 52.66%

	FY22	Y/Y Change
Revenue	$16.0M	↓ 5.1%
Net Income	$-22.7M	↑ 11.66%
Net Profit Margin	-141.41%	↓ 21.23%

	FY23	Y/Y Change
Revenue	$13.8M	↓ 13.87%
Net Income	$-13.6M	↓ 40.05%
Net Profit Margin	-98.42%	↑ 42.99%

	FY24	Y/Y Change
Revenue	$13.8M	↑ 0.0%
Net Income	$-13.6M	↑ 0.0%
Net Profit Margin	-98.42%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	$3.4M	↓ 11.98%
Net Income	$-5.5M	↓ 215.79%
Net Profit Margin	-162.83%	↓ 286.6%

	Q3 FY23	Q/Q Change
Revenue	$3.3M	↓ 2.77%
Net Income	$-2.1M	↓ 62.14%
Net Profit Margin	-63.41%	↑ 99.42%

	Q4 FY23	Q/Q Change
Revenue	$3.2M	↓ 1.61%
Net Income	$-4.3M	↑ 103.49%
Net Profit Margin	-131.13%	↓ 67.72%

	Q1 FY24	Q/Q Change
Revenue	$3.4M	↑ 5.26%
Net Income	$-3.8M	↓ 11.65%
Net Profit Margin	-110.06%	↑ 21.07%

	Q2 FY24	Q/Q Change
Revenue	$4.1M	↑ 18.57%
Net Income	$-1.9M	↓ 48.71%
Net Profit Margin	-47.61%	↑ 62.45%

	Q3 FY24	Q/Q Change
Revenue	$3.9M	↓ 4.79%
Net Income	$-2.6M	↑ 35.54%
Net Profit Margin	-67.77%	↓ 20.16%

	FY19	Y/Y Change
Profit	$8.7M	↑ 219.38%

	FY20	Y/Y Change
Profit	$10.4M	↑ 20.28%

	FY21	Y/Y Change
Profit	$12.6M	↑ 21.04%

	FY22	Y/Y Change
Profit	$10.0M	↓ 20.51%

	FY23	Y/Y Change
Profit	$7.7M	↓ 23.65%

	FY24	Y/Y Change
Profit	$8.3M	↑ 8.12%

	Q2 FY23	Q/Q Change
Profit	$2.1M	↓ 10.23%

	Q3 FY23	Q/Q Change
Profit	$1.9M	↓ 9.53%

	Q4 FY23	Q/Q Change
Profit	$1.8M	↓ 5.74%

	Q1 FY24	Q/Q Change
Profit	$1.9M	↑ 8.27%

	Q2 FY24	Q/Q Change
Profit	$2.7M	↑ 36.86%

	Q3 FY24	Q/Q Change
Profit	$2.3M	↓ 11.96%

	FY19	Y/Y Change
Operating Cash Flow	$-5.3M	↑ 0.5%
Investing Cash Flow	$86.2K	↓ 107.72%
Financing Cash Flow	$4.5M	↓ 14.93%

	FY20	Y/Y Change
Operating Cash Flow	$-5.7M	↑ 6.36%
Investing Cash Flow	$-120.3K	↓ 239.47%
Financing Cash Flow	$23.5M	↑ 426.68%

	FY21	Y/Y Change
Operating Cash Flow	$-15.7M	↑ 177.01%
Investing Cash Flow	$-2.6M	↑ 2068.78%
Financing Cash Flow	$24.2M	↑ 2.68%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.9M	↓ 19.21%
Investing Cash Flow	$-245.0K	↑ 0.0%
Financing Cash Flow	$0.0	↓ 100.0%

Vivos Therapeutics Technicals Summary

Sell

Neutral

Buy

Vivos Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Vivos Therapeutics (VVOS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vivos Therapeutics Inc	15.38%	22.87%	-20.88%	-94.33%	-98.4%
Medtronic Plc	0.43%	0.52%	8.52%	-16.72%	4.04%
Edwards Lifesciences Corp.	-3.87%	4.6%	-24.37%	-37.3%	10.71%
Boston Scientific Corp.	-3.64%	19.87%	49.64%	131.47%	236.53%
Stryker Corporation	-3.05%	1.25%	5.72%	39.52%	142.48%
Abbott Laboratories	-6.38%	10.04%	14.84%	6.21%	78.57%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vivos Therapeutics Inc	NA	NA	NA	-1.79	-3.26	-0.61	NA	1.61
Medtronic Plc	27.79	27.79	1.57	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.11	30.11	5.54	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	81.2	81.2	2.0	2.86	0.09	0.05	NA	14.76
Stryker Corporation	48.32	48.32	2.11	13.47	0.15	0.07	0.01	54.1
Abbott Laboratories	16.54	16.54	4.17	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vivos Therapeutics Inc	Buy	$21.2M	-98.4%	NA	-86.19%
Medtronic Plc	Buy	$117.0B	4.04%	27.79	12.83%
Edwards Lifesciences Corp.	Buy	$41.4B	10.71%	30.11	76.75%
Boston Scientific Corp.	Buy	$150.1B	236.53%	81.2	11.07%
Stryker Corporation	Buy	$142.8B	142.48%	48.32	13.25%
Abbott Laboratories	Buy	$219.9B	78.57%	16.54	31.95%

About Vivos Therapeutics

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Organization	Vivos Therapeutics
Employees	114
CEO	Mr. R. Kirk Huntsman
Industry	Miscellaneous

Management People of Vivos Therapeutics

Name	Title
Mr. R. Kirk Huntsman	Co-Founder, Chairman of the Board & CEO
Mr. Bradford K. Amman	CFO, Treasurer & Secretary
Mr. Todd Huntsman	Co-Founder & Senior VP of Product and Technology
Ms. RaeAnn Byrnes	Co-Founder and Senior VP of Events & Clinical Advisory Services
Ms. Susan McCullough	Co-Founder & Executive VP of Operations
Mr. Nicholas M. DeGennaro	Senior Vice President of Medical Integration Division
Ms. Ruth Hembree	Senior Vice President of Practice Services
Ms. Stephanie Huebner	Senior Vice President of Dental Service Integration
Mr. John Ballard	Senior Vice President of Technology

Important FAQs about investing in VVOS Stock from India :

What is Vivos Therapeutics share price today?

Vivos Therapeutics share price today stands at $3.60, Open: $3.52 ; Previous Close: $3.51 ; High: $3.68 ; Low: $3.45 ; 52 Week High: $6.28 ; 52 Week Low: $1.91.

The stock opens at $3.52, after a previous close of $3.51. The stock reached a daily high of $3.68 and a low of $3.45, with a 52-week high of $6.28 and a 52-week low of $1.91.

Can Indians buy Vivos Therapeutics shares?

Yes, Indians can invest in the Vivos Therapeutics (VVOS) from India.

With INDmoney, you can buy Vivos Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Vivos Therapeutics at zero transaction cost.

How can I buy Vivos Therapeutics shares from India?

It is very easy to buy Vivos Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vivos Therapeutics (VVOS) be purchased?

Yes, you can buy fractional shares of Vivos Therapeutics with INDmoney app.

What are the documents required to start investing in Vivos Therapeutics stocks?

To start investing in Vivos Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.